Sichuan Gangtong Medical Equipment Group Co., Ltd (SHE:301515)
China · Delayed Price · Currency is CNY 20.21
+0.02 (0.10%)
At close: Oct 9, 2026
SHE:301515 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 1,941 | 1,927 | 1,784 | 2,862 | - | - | |
Market Cap Growth | -7.28% | 7.97% | -37.65% | - | - | - |
Enterprise Value | 1,516 | 1,549 | 1,244 | 2,251 | - | - |
Last Close Price | 20.21 | 20.06 | 17.88 | 27.91 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 123.72 | 34.44 | - | - |
PS Ratio | 2.66 | 2.67 | 2.37 | 3.40 | - | - |
PB Ratio | 1.61 | 1.58 | 1.39 | 2.15 | - | - |
P/TBV Ratio | 1.64 | 1.60 | 1.41 | 2.19 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.08 | 2.15 | 1.65 | 2.67 | - | - |
EV/EBITDA Ratio | - | - | 203.62 | 31.32 | - | - |
EV/EBIT Ratio | - | - | 6411.13 | 33.99 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.29 | 0.20 | 0.16 | 0.09 | 0.16 | 0.17 |
Debt / EBITDA Ratio | - | 2204.65 | 16.72 | 1.63 | 0.96 | 0.97 |
Debt / FCF Ratio | - | - | - | - | 2.08 | 9.58 |
Net Debt / Equity Ratio | -0.35 | -0.37 | -0.40 | -0.47 | -0.10 | -0.02 |
Net Debt / EBITDA Ratio | 24.45 | 78.22 | -84.44 | -8.78 | -0.64 | -0.13 |
Net Debt / FCF Ratio | 9.82 | 12.78 | 10.76 | 4.41 | -1.33 | -1.23 |
Asset Turnover | 0.36 | 0.36 | 0.38 | 0.53 | 0.71 | 0.71 |
Inventory Turnover | 2.25 | 2.32 | 2.43 | 2.47 | 2.41 | 2.10 |
Quick Ratio | 1.97 | 1.94 | 2.45 | 2.40 | 1.34 | 1.14 |
Current Ratio | 2.40 | 2.33 | 2.80 | 2.89 | 1.75 | 1.72 |
Return on Equity (ROE) | -1.31% | -0.41% | 1.10% | 8.83% | 14.24% | 15.76% |
Return on Assets (ROA) | -0.80% | -0.41% | 0.01% | 2.62% | 4.76% | 4.98% |
Return on Invested Capital (ROIC) | -3.33% | -1.71% | 0.03% | 9.72% | 15.10% | 16.05% |
Return on Capital Employed (ROCE) | -2.00% | -1.00% | 0.00% | 4.80% | 13.90% | 14.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | -0.65% | -0.14% | 0.81% | 2.90% | - | - |
FCF Yield | -2.22% | -1.83% | -2.69% | -5.00% | - | - |
Dividend Yield | - | - | 0.67% | 0.92% | - | - |
Payout Ratio | - | - | 281.17% | 4.21% | 8.99% | 20.85% |
Buyback Yield / Dilution | 1.89% | 2.73% | -16.20% | -13.89% | 0.00% | -0.00% |
Total Shareholder Return | 1.89% | 2.73% | -15.53% | -12.97% | 0.00% | -0.00% |